Position in PCVX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,984
-$228,125 QoQ
Shares Held
361
-93.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#268
of 330 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantbot Technologies LP holds $29,328,891 across 118 Biotechnology names. PCVX ranks #100 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
80,193 | $4,496,421 | |
| 2 | TECH |
BIO-TECHNE Corp
|
52,802 | $3,730,461 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
5,724 | $1,071,990 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
17,880 | $975,175 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,460 | $910,368 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,831 | $882,834 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
6,302 | $836,464 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
|
8,884 | $788,721 |
All Filings in PCVX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,984 | 361 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $249,109 | 5,399 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $221,750 | 6,821 | Shares | Sole | 2025-08-13 | |
| 2024-03-31 | $3,893 | 57 | Shares | Sole | 2024-05-06 | |
| 2022-12-31 | $1,059,695 | 22,100 | Shares | Sole | 2023-02-13 | |
| 2021-12-31 | $42,822 | 1,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $83,721 | 3,300 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $33,765 | 1,500 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||